3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
5
Vipoma
4
Carcinoma, Islet Cell
4
Somatostatinoma
3
Neuroendocrine Tumors
3
Intestinal Obstruction
3
Insulinoma
3
Glucagonoma
3
Gastrinoma
3
Carcinoma, Hepatocellular
3
Thymoma
2
Stomach Neoplasms
2
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Meningioma
2
Diarrhea
2
Carcinoma
2
Carcinoid Tumor
2
Adenoma, Islet Cell
2
Weight Loss
1
Waldenstrom Macroglobulinemia
1
Vomiting
1
Recurrence
1
Rectal Neoplasms
1
Primary Inoperable Thymoma
1
Pleural Effusion
1
Pheochromocytoma
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
Cisplatin
88
Fluorouracil
71
Paclitaxel
69
Radiotherapy
63
Oxaliplatin
55
Irinotecan
37
Docetaxel
36
Carboplatin
36
Leucovorin
34
Capecitabine
28
Radiation
25
Surgical Procedures, Operative
22
Drug Therapy
19
pembrolizumab
18
Cetuximab
15
Bevacizumab
15
Nivolumab
14
tislelizumab
12
camrelizumab
11
Neoadjuvant Therapy
11
Esophagectomy
11
Chemoradiotherapy
11
S 1 (combination)
10
Albumin-Bound Paclitaxel
10
nimotuzumab
9
Trastuzumab
9
durvalumab
8
Radiotherapy, Intensity-Modulated
8
Gefitinib
7
Epirubicin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Esophageal Neoplasms
×
Octreotide
×
Clear all
NCT04871204
2024-10-31
OTIS
Karolinska University Hospital
Phase 2
Completed
20 enrolled